Acquisition Blogging Study Venture Capital 
Both Sides of the Table
SEPTEMBER 15, 2022
At our mid-year offsite our partnership at Upfront Ventures was discussing what the future of venture capital and the startup ecosystem looked like. No blog post about how Tiger is crushing everybody because it’s deploying all its capital in 1-year while “suckers” are investing over 3-years can change this reality.
Both Sides of the Table
APRIL 21, 2010
Finally, a lot of people asking me about typos on my blog. Studying for the SAT, LSAT, GMAT, TOEFL, MCAT and other standardized tests in the US is a massive market that has been dominated for years by Kaplan and Princeton Review. Investors: True Ventures, Social Leverage (Howard Lindzon). 2.2mm in Series A. It sucked.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Both Sides of the Table
SEPTEMBER 8, 2009
I was reading Chris Dixon’s blog tonight. I came across this blog post about getting a computer science degree as the best degree for getting into venture capital or working at a VC-backed start up. I just completed an exercise where I went out to hire a new associate for my VC firm, GRP Partners.
Both Sides of the Table
AUGUST 12, 2010
In the technology world there are a few websites that most startups track to keep up with the latest financings, acquisitions, product announcements and gossip: BusinessInsider, TechCrunch, Mashable, GigaOm, etc. In the VC & Private Equity world there’s a small number, too, with one of the most respected being PEHub.
Both Sides of the Table
MAY 25, 2013
But VC is like congress. “I don’t know the exact math, but I hear it again and again: the top 2% of firms generate 98% of the returns in venture capital.” As you can see from the chart their data suggests there are about $25 billion of VC distributions per year in the US. Their data looks at tech VCs.
Both Sides of the Table
JULY 25, 2010
I recently read a book I’d highly recommend to every reader of this blog called “ Yes, 50 Scientifically Proven Ways to be Persuasive &# by Robert B. The book is a layman’s guide to understanding how we as humans make decisions and is underpinned by data-oriented studies to prove his claims. You should, too. (no,
Xconomy
MAY 4, 2018
Here’s a case study of how fast things can change in biopharma. Through acquisitions and alliances, they rolled out a spate of large-scale combination trials. For a few years, a type of cancer drug called an IDO inhibitor was all the rage, a promising path to expanding the reach of immunotherapy. Major drug makers were dealing, too.
Expert insights. Personalized for you.
416 
Let's personalize your content